Zobrazeno 1 - 10
of 483
pro vyhledávání: '"Naber KG"'
Autor:
Naber KG
Publikováno v:
Research and Reports in Urology, Vol 2013, Iss default, Pp 39-46 (2013)
Kurt G NaberTechnical University, Munich, GermanyAbstract: This review evaluates 17 clinical studies from 18 selected publications concerning the safety, tolerability, and additional effects of the phytotherapeutic drug, Canephron® N (CAN, containin
Externí odkaz:
https://doaj.org/article/dc76cc16340e4a20ac8378e112636763
Autor:
Naber KG
Publikováno v:
International Journal of General Medicine, Vol 2011, Iss default, Pp 755-757 (2011)
Kurt G NaberTechnical University of Munich, Munich, GermanyMinardi et al1 have described well-established risk factors for recurrent urinary tract infection (UTI) and have emphasized the importance of a clear communication with the patient in order t
Externí odkaz:
https://doaj.org/article/00e94e356685455f933e45048d418d58
Publikováno v:
GMS Infectious Diseases; VOL: 10; DOC01 /20220324/
Introduction: Urinary tract infections (UTI) are a leading cause of bacterial infections in women. Despite acute treatment, 30-50% of women who have a UTI will experience a recurrence within 6-12 months. In this review, the focus will be on the perso
Antimicrobial susceptibility testing (AST) performed according to defined guidelines is important to identify resistance and to predict the clinical success or failure of specific antibiotic therapy. However, these guidelines do not cover all physiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::e04a0a2ebb7aaa72b303462e801c6260
https://openaccess.sgul.ac.uk/id/eprint/111617/1/fmicb-11-00054.pdf
https://openaccess.sgul.ac.uk/id/eprint/111617/1/fmicb-11-00054.pdf
Publikováno v:
Infektiologie Update 2018; 26. Jahrestagung der Paul-Ehrlich-Gesellschaft für Chemotherapie (PEG); 20181004-20181006; Wien; DOC18peg23 /20181008/
Einführung: Anhand der interdisziplinären AWMF S3-Leitlinie kann die Diagnose einer akuten, unkomplizierten Zystitis (AUZ) in der Regel mittels der typischen Symptome (z.B. Dysurie, Pollakisurie, Harndrang) bei Abwesenheit von vaginalen Irritatione
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614b54fb3459ad6acad09e8703c60f70
Publikováno v:
Translational Andrology and Urology
Introduction The Uzbek and Russian versions of the Acute Cystitis Symptom Score (ACSS) were developed as a simple self-reporting questionnaire helping to assess the typical and differential symptoms of AUC, their impact on quality of life and possibl
Autor:
PREZIOSO, DOMENICO, BARTOLETTI R, CAI T, MONDAINI N, DINELLI N, PINZI N, PAVONE C, GONTERO P, GAVAZZI A, GIUBILEI G, MAZZOLI S, BODDI V, NABER KG, ITALIAN PROSTATITIS STUDY GROUP
PURPOSE: We evaluated the prevalence and estimated the incidence and risk factors of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy. MATERIALS AND METHODS: From January to June 2006 patients from 28 Itali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::b274e1d03687e91aeea85d837c1923d8
http://hdl.handle.net/11588/158063
http://hdl.handle.net/11588/158063
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 18:783-789
Twelve healthy volunteers participated in a randomized crossover study to compare urinary concentrations, serum parameters, and urinary bactericidal activity of ciprofloxacin after single intravenous (i.v.) doses of 200 mg and 400 mg and an oral (p.o
Autor:
Wolfgang Weidner, Naber Kg
Publikováno v:
Aktuelle Urologie. 37:269-271
The classification of prostatitis into four categories is based on the well accepted NIH definition. Based on this classification, the consensus conference has made suggestions on the diagnostic management and therapy for all types of prostatitis.
Autor:
Wagenlehner, Fm, van Oostrum, E, Tenke, P, Tandogdu, Z, Çek, M, Grabe, M, Wullt, B, Pickard, R, Naber, Kg, Pilatz, A, Weidner, W, Bjerklund Johansen TE, Gpiu, Investigators, Costantini, Elisabetta
Publikováno v:
Wagenlehner, F M E, van Oostrum, E, Tenke, P, Tandogdu, Z, Çek, M, Grabe, M, Wullt, B, Pickard, R, Naber, K G, Pilatz, A, Weidner, W, Johansen, T E B & GPIU investigators 2013, ' Infective complications after prostate biopsy : outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study ', European Urology, vol. 63, no. 3, pp. 521-7 . https://doi.org/10.1016/j.eururo.2012.06.003
Background Infection is a serious adverse effect of prostate biopsy (P-Bx), and recent reports suggest an increasing incidence. Objective The aim of this multinational multicentre study was to evaluate prospectively the incidence of infective complic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96bf84733d11b3966e0a5e136285c17d
http://hdl.handle.net/11391/1099065
http://hdl.handle.net/11391/1099065